Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine

Pediatric Infectious Disease Journal

Volumn 31, Issue 3, 2012, Pages 249-254

  Wroe, Peter C ^a   Lee, Grace M ^a,b   Finkelstein, Jonathan A ^a,b   Pelton, Stephen I ^c   Hanage, William P ^d   Lipsitch, Marc ^e   Stevenson, Abbie E ^c   Rifas Shiman, Sheryl L ^a   Kleinman, Ken ^a   Dutta Linn, M Maya ^a   Hinrichsen, Virginia L ^a   Lakoma, Matthew ^a   Huang, Susan S ^f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antibiotic resistance; colonization; pneumococcal conjugate vaccine; serotype; Streptococcus pneumoniae

Indexed keywords

13 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; 7 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; AMOXICILLIN; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CHILD; CROSS-SECTIONAL STUDY; GROUPS BY AGE; HUMAN; INFANT; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; WINTER;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MASSACHUSETTS; MICROBIAL SENSITIVITY TESTS; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; QUESTIONNAIRES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84857628295     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31824214ac     Document Type: Article

References (44)

1. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. Morb Mortal Wkly Rep. 2005;54:893-897.
2. Black S, Shinefield H, Baxter R, et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004;23:485-489. (Pubitemid 38802290)
3. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis. 2007;196:1346-1354. (Pubitemid 351412007)
4. Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006;295:1668-1674.
5. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746. (Pubitemid 36514704)
6. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409. (Pubitemid 32128672)
7. Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;369:1179-1186. (Pubitemid 46527876)
8. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118:865-873. (Pubitemid 46090026)
9. Flannery B, Heffernan RT, Harrison LH, et al. Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med. 2006;144:1-9. (Pubitemid 46780714)
10. Lexau CA, Lynfield R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005;294:2043-2051. (Pubitemid 41539937)
11. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32-41.
12. Ghaffar F, Barton T, Lozano J, et al. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin Infect Dis. 2004;39:930-938. (Pubitemid 39313446)
13. Huang SS, Platt R, Rifas-Shiman SL, et al. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005;116:e408-e413. (Pubitemid 44336655)
14. Pelton SI, Loughlin AM, Marchant CD. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J. 2004;23:1015-1022. (Pubitemid 40824291)
15. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae-Massachusetts, 2001-2006. Morb Mortal Wkly Rep. 2007;56: 1077-1080.
16. Byington CL, Samore MH, Stoddard GJ, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis. 2005;41: 21-29. (Pubitemid 40863739)
17. Jacobs MR, Good CE, Beall B, et al. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. J Clin Microbiol. 2008;46:982-990. (Pubitemid 351379990)
18. Park SY, Moore MR, Bruden DL, et al. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J. 2008;27:335-340. (Pubitemid 351483069)
19. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297:1784-1792. (Pubitemid 46658647)
20. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2005. Morb Mortal Wkly Rep. 2008;57: 144-148.
21. Huang SS, Hinrichsen VL, Stevenson AE, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124:e1-e11.
22. Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. In press.
23. Hanage WP, Huang SS, Lipsitch M, et al. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis. 2007;195:347-352. (Pubitemid 46146111)
24. Moore MR, Gertz RE Jr, Woodbury RL, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis. 2008;197:1016-1027. (Pubitemid 351590031)
25. Pelton SI, Huot H, Finkelstein JA, et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007;26:468-472. (Pubitemid 46847304)
26. Pai R, Moore MR, Pilishvili T, et al. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis. 2005;192:1988-1995. (Pubitemid 41681898)
27. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010. Morb Mortal Wkly Rep. 2010;59:258-261.
28. Finkelstein JA, Huang SS, Daniel J, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics. 2003;112:862-869. (Pubitemid 37258325)
29. Hanage WP, Bishop CJ, Huang SS, et al. Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr Infect Dis J. 2011;30:302-308.
30. Janapatla RP, Hsu MH, Du JF, et al. Sequence types and antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates from a region with high antibiotic selective pressure and suboptimal vaccine coverage. Pediatr Infect Dis J. 2010;29:467-469.
31. Pillai DR, Shahinas D, Buzina A, et al. Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics. 2009;10:642.
32. Nahm MH, Lin J, Finkelstein JA, et al. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis. 2009;199: 320-325.
33. Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2004.
34. Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
35. van Gils EJ, Veenhoven RH, Hak E, et al. Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. JAMA. 2010;304:1099-1106.
36. Imohl M, Reinert RR, van der Linden M. Temporal variations among invasive pneumococcal disease serotypes in children and adults in Germany (1992-2008). Int J Microbiol. 2010;2010:874189.
37. Steenhoff AP, Shah SS, Ratner AJ, et al. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clin Infect Dis. 2006; 42:907-914.
38. Park IH, Moore MR, Treanor JJ, et al. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis. 2008;198:1818-1822.
39. Brueggemann AB, Griffiths DT, Meats E, et al. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis. 2003; 187:1424-1432. (Pubitemid 36549688)
40. Hanage WP, Auranen K, Syrjanen R, et al. Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect Immun. 2004;72: 76-81. (Pubitemid 38018163)
41. Hanage WP, Kaijalainen TH, Syrjanen RK, et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun. 2005;73:431-435. (Pubitemid 40041136)
42. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004;113(3 pt 1):443-449. (Pubitemid 38280781)
43. Mufson MA, Stanek RJ. Epidemiology of invasive Streptococcus pneumoniae infections and vaccine implications among children in a West Virginia community, 1978-2003. Pediatr Infect Dis J. 2004;23:779-781. (Pubitemid 39063297)
44. Hanage WP, Fraser C, Tang J, et al. Hyper-recombination, diversity, and antibiotic resistance in pneumococcus. Science. 2009;324:1454-1457.